This federal contract award, valued at $2,433.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Lacosamide 10 mg/ml solution in 200 ml bottles, a prescription medication used to treat certain types of epilepsy.
The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of December 3, 2024. It is not designated as a set-aside contract, indicating open competition.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Generated 3/9/25, 12:47 AM